So PR is indicating that JV partners are pretty much locked in and are waiting on Phase III approval.
Approximately AUD$90mill required for Phase III trial
No indication yet that he is looking to put a new chairman of the board in place
FDA approval late 2026/2027 barring delays
TGA approval possibly late 2025.
So PR is indicating that JV partners are pretty much locked in...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $68.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 517 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 1310 | 2 |
View Market Depth
| Last trade - 09.40am 02/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
Day chart unavailable